Dupixent (dupilumab)
https://assets.ctfassets.net/plyq12u1bv8a/5qYG3sMTDAsfgHzsn07AJ/a1f17cb727c60b9a9201bad7d5538197/PG026_Dupixent.pdf
WebDupixent (dupilumab) is an interleukin-4 receptor alpha agonist indicated for the following conditions: Atopic dermatitis, moderate to severe - Dupilumab is indicated as treatment of patients aged 6 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies
DA: 50 PA: 15 MOZ Rank: 100